Matches in SemOpenAlex for { <https://semopenalex.org/work/W4383163964> ?p ?o ?g. }
- W4383163964 abstract "According to clinical practice guidelines, transarterial chemoembolization (TACE) is the standard treatment modality for patients with intermediate-stage hepatocellular carcinoma (HCC). Early prediction of treatment response can help patients choose a reasonable treatment plan. This study aimed to investigate the value of the radiomic-clinical model in predicting the efficacy of the first TACE treatment for HCC to prolong patient survival. A total of 164 patients with HCC who underwent the first TACE from January 2017 to September 2021 were analyzed. The tumor response was assessed by modified response evaluation criteria in solid tumors (mRECIST), and the response of the first TACE to each session and its correlation with overall survival were evaluated. The radiomic signatures associated with the treatment response were identified by the least absolute shrinkage and selection operator (LASSO), and four machine learning models were built with different types of regions of interest (ROIs) (tumor and corresponding tissues) and the model with the best performance was selected. The predictive performance was assessed with receiver operating characteristic (ROC) curves and calibration curves. Of all the models, the random forest (RF) model with peritumor (+10 mm) radiomic signatures had the best performance [area under ROC curve (AUC) = 0.964 in the training cohort, AUC = 0.949 in the validation cohort]. The RF model was used to calculate the radiomic score (Rad-score), and the optimal cutoff value (0.34) was calculated according to the Youden's index. Patients were then divided into a high-risk group (Rad-score > 0.34) and a low-risk group (Rad-score ≤ 0.34), and a nomogram model was successfully established to predict treatment response. The predicted treatment response also allowed for significant discrimination of Kaplan-Meier curves. Multivariate Cox regression identified six independent prognostic factors for overall survival, including male [hazard ratio (HR) = 0.500, 95% confidence interval (CI): 0.260–0.962, P = 0.038], alpha-fetoprotein (HR = 1.003, 95% CI: 1.002–1.004, P < 0.001), alanine aminotransferase (HR = 1.003, 95% CI: 1.001–1.005, P = 0.025), performance status (HR = 2.400, 95% CI: 1.200–4.800, P = 0.013), the number of TACE sessions (HR = 0.870, 95% CI: 0.780–0.970, P = 0.012) and Rad-score (HR = 3.480, 95% CI: 1.416–8.552, P = 0.007). The radiomic signatures and clinical factors can be well-used to predict the response of HCC patients to the first TACE and may help identify the patients most likely to benefit from TACE." @default.
- W4383163964 created "2023-07-05" @default.
- W4383163964 creator A5002609263 @default.
- W4383163964 creator A5019336862 @default.
- W4383163964 creator A5031133119 @default.
- W4383163964 creator A5034816956 @default.
- W4383163964 creator A5036490226 @default.
- W4383163964 creator A5044289648 @default.
- W4383163964 creator A5066713108 @default.
- W4383163964 creator A5081488787 @default.
- W4383163964 creator A5083419929 @default.
- W4383163964 date "2023-07-01" @default.
- W4383163964 modified "2023-09-27" @default.
- W4383163964 title "Computed tomography radiomic features and clinical factors predicting the response to first transarterial chemoembolization in intermediate-stage hepatocellular carcinoma" @default.
- W4383163964 cites W2015801294 @default.
- W4383163964 cites W2018786027 @default.
- W4383163964 cites W2025193851 @default.
- W4383163964 cites W2106787323 @default.
- W4383163964 cites W2108517168 @default.
- W4383163964 cites W2125763116 @default.
- W4383163964 cites W2300587681 @default.
- W4383163964 cites W2765938943 @default.
- W4383163964 cites W2802633445 @default.
- W4383163964 cites W2884600812 @default.
- W4383163964 cites W2885326465 @default.
- W4383163964 cites W2891000805 @default.
- W4383163964 cites W2896617188 @default.
- W4383163964 cites W2917245118 @default.
- W4383163964 cites W2953559648 @default.
- W4383163964 cites W2966119159 @default.
- W4383163964 cites W3022156378 @default.
- W4383163964 cites W3095301789 @default.
- W4383163964 cites W3099357028 @default.
- W4383163964 cites W3119510676 @default.
- W4383163964 cites W3126359978 @default.
- W4383163964 cites W3153073605 @default.
- W4383163964 cites W3207894116 @default.
- W4383163964 cites W4242769447 @default.
- W4383163964 doi "https://doi.org/10.1016/j.hbpd.2023.06.011" @default.
- W4383163964 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37429785" @default.
- W4383163964 hasPublicationYear "2023" @default.
- W4383163964 type Work @default.
- W4383163964 citedByCount "0" @default.
- W4383163964 crossrefType "journal-article" @default.
- W4383163964 hasAuthorship W4383163964A5002609263 @default.
- W4383163964 hasAuthorship W4383163964A5019336862 @default.
- W4383163964 hasAuthorship W4383163964A5031133119 @default.
- W4383163964 hasAuthorship W4383163964A5034816956 @default.
- W4383163964 hasAuthorship W4383163964A5036490226 @default.
- W4383163964 hasAuthorship W4383163964A5044289648 @default.
- W4383163964 hasAuthorship W4383163964A5066713108 @default.
- W4383163964 hasAuthorship W4383163964A5081488787 @default.
- W4383163964 hasAuthorship W4383163964A5083419929 @default.
- W4383163964 hasConcept C121332964 @default.
- W4383163964 hasConcept C126322002 @default.
- W4383163964 hasConcept C126838900 @default.
- W4383163964 hasConcept C146357865 @default.
- W4383163964 hasConcept C151730666 @default.
- W4383163964 hasConcept C2778019345 @default.
- W4383163964 hasConcept C2778217198 @default.
- W4383163964 hasConcept C2779984678 @default.
- W4383163964 hasConcept C2989005 @default.
- W4383163964 hasConcept C31760486 @default.
- W4383163964 hasConcept C43346845 @default.
- W4383163964 hasConcept C535046627 @default.
- W4383163964 hasConcept C58471807 @default.
- W4383163964 hasConcept C62520636 @default.
- W4383163964 hasConcept C71924100 @default.
- W4383163964 hasConcept C72563966 @default.
- W4383163964 hasConcept C76318530 @default.
- W4383163964 hasConcept C86803240 @default.
- W4383163964 hasConceptScore W4383163964C121332964 @default.
- W4383163964 hasConceptScore W4383163964C126322002 @default.
- W4383163964 hasConceptScore W4383163964C126838900 @default.
- W4383163964 hasConceptScore W4383163964C146357865 @default.
- W4383163964 hasConceptScore W4383163964C151730666 @default.
- W4383163964 hasConceptScore W4383163964C2778019345 @default.
- W4383163964 hasConceptScore W4383163964C2778217198 @default.
- W4383163964 hasConceptScore W4383163964C2779984678 @default.
- W4383163964 hasConceptScore W4383163964C2989005 @default.
- W4383163964 hasConceptScore W4383163964C31760486 @default.
- W4383163964 hasConceptScore W4383163964C43346845 @default.
- W4383163964 hasConceptScore W4383163964C535046627 @default.
- W4383163964 hasConceptScore W4383163964C58471807 @default.
- W4383163964 hasConceptScore W4383163964C62520636 @default.
- W4383163964 hasConceptScore W4383163964C71924100 @default.
- W4383163964 hasConceptScore W4383163964C72563966 @default.
- W4383163964 hasConceptScore W4383163964C76318530 @default.
- W4383163964 hasConceptScore W4383163964C86803240 @default.
- W4383163964 hasFunder F4320312270 @default.
- W4383163964 hasLocation W43831639641 @default.
- W4383163964 hasLocation W43831639642 @default.
- W4383163964 hasOpenAccess W4383163964 @default.
- W4383163964 hasPrimaryLocation W43831639641 @default.
- W4383163964 hasRelatedWork W2090940335 @default.
- W4383163964 hasRelatedWork W2124159354 @default.
- W4383163964 hasRelatedWork W2364996258 @default.
- W4383163964 hasRelatedWork W2393788157 @default.
- W4383163964 hasRelatedWork W2414570500 @default.
- W4383163964 hasRelatedWork W2596974952 @default.